Taking vitamin E does not impact women's heart failure risk

March 20, 2012

Taking vitamin E supplements does not increase or decrease heart failure risk among women, according to a study in Circulation: Heart Failure, an American Heart Association journal.

The study is the first to investigate the effectiveness of to prevent the development of heart failure. Researchers studied nearly 40,000 women in the Women's who took 600 International Units of vitamin E or placebo every other day. The women were age 45 or older and healthy at the study's start. Researchers followed them for an average 10.2 years to determine if taking the supplement affected heart failure risk. Investigators recorded 220 heart failure cases.

Overall, researchers found no impact from vitamin E supplementation.

They did, however, observe a 41 percent decrease in the risk of developing a type of heart failure in which the heart retains its normal pumping function. This sub finding is only an observation and topic for future research, said Claudia U. Chae, M.D., M.P.H, lead researcher in the cardiology division at Massachusetts General Hospital in Boston.

They conclude: vitamin E does not prevent heart failure. Prevention strategies should instead focus on what has been shown in research to reduce risk, such as controlling blood pressure and preventing heart disease.

Explore further: Healthy lifestyle habits lower heart failure risk

Related Stories

Healthy lifestyle habits lower heart failure risk

September 13, 2011

If you don't smoke, aren't overweight, get regular physical activity and eat vegetables, you can significantly reduce your risk for heart failure, according to research reported in Circulation: Heart Failure, an American ...

Recommended for you

No new heart muscle cells in mice after the newborn period

November 5, 2015

A new study from Sweden's Karolinska Institutet shows that new heart muscle cells in mice are mainly formed directly after birth. After the neonatal period the number of heart muscle cells does not change, and A new study ...

Nanotechnology could spur new heart treatment

October 29, 2015

A new nanoparticle developed by University of Michigan researchers could be the key to a targeted therapy for cardiac arrhythmia, a condition that causes the heart to beat erratically and can lead to heart attack and stroke.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.